News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/12TRANSCRIPT : Apollo Hospitals Enterprise Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/12Shanghai MicroPort MedBot Co., Ltd. Announces Address Change
CI
08/12European shares rise as healthcare, leisure stocks gain
RE
08/12WuXi Biologics Inc. Announces Change of Address of Principal Place of Business in Hong Kong
CI
08/12TRANSCRIPT : Divi's Laboratories Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/12GSK, Sanofi and Haleon shares stabilise after Zantac litigation slump
RE
08/12PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/12Clinical Laserthermia Systems AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12ShareHope Medicine Co., Ltd. Announces Cash Dividend, Payable on October 4, 2022
CI
08/12N G Industries LTD Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/12AusCann Group Holdings Ltd Appoints Chris Mews as Chief Financial Officer
CI
08/12European shares eke out gains at open as healthcare stocks rebound
RE
08/12Linical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023
CI
08/12Linical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
CI
08/12Divi's Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Discover
08/12Medilines Distributors Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12SANOFI : Upgraded to Neutral by Deutsche Bank
MD
08/12Kringle Pharma, Inc. Updates on the Investigator-initiated Phase 2 Study in Patients with ALS
CI
08/12GSK, Sanofi, Haleon Shares Recover Some Recent Losses After Zantac Drug Responses
DJ
08/12Chong Kun Dang Holdings Corp. announces an Equity Buyback for KRW 10,000 million worth of its shares.
CI
08/12Taiko Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Quarter End December 2022
CI
08/12Asahi Intecc Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter and Fiscal Year Ending June 30, 2023
CI
08/12Asahi Intecc Co., Ltd. Announces Dividend for the Fiscal Year Ended June 30, 2022, Payable on September 30, 2022 and Provides Dividend Guidance for the Fiscal Year Ending June 30, 2023
CI
08/12Bioservo Technologies AB Signs an Agreement for the Sale of Carbonhand with Rehasys in Switzerland
CI
08/12Fabino Life Sciences Limited Appoints Aslam Mohamrnad as Company Secretary and Compliance Officer
CI
08/12Kobo Biotech Limited Announces Change in Registered Office Address
CI
08/12Ramsay Health Care Limited and Bupa Reach In-Principle Agreement
CI
08/12Perseus Proteomics Inc. Provides Earnings Guidance for the Year Ending March 31, 2023
CI
08/12GSK Says FDA, EMA Conclude No Evidence Of Causal Association Between Ranitidine Therapy, Development Of Cancer
RE
08/12Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/12Nexstim Plc Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/12Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
CI
08/12Nexstim Plc Provides Earnings Guidance for the Year 2022
CI
08/12InnoCare Pharma Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
CI
08/12Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/12Haleon Says It Hasn't Been Notified About Litigation on Zantac Drug -- Update
DJ
08/12Roche Announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
CI
08/12Pihlajalinna Oyj Reiterates Earnings Guidance for the Year 2022
CI
08/12Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023
CI
08/12Menicon Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023
CI
08/12Pihlajalinna Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12AstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer Treatment
DJ
08/12TRANSCRIPT : Aster DM Healthcare Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/12Haleon Says it Hasn't Been Notified About Litigation on Zantac Drug
DJ
08/12Yunkang Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2022
CI
08/12EPIZYME, INC.(NASDAQGS : EPZM) dropped from S&P Global BMI Index
CI
08/12EPIZYME, INC.(NASDAQGS : EPZM) dropped from S&P TMI Index
CI
08/11Singbao International Co. Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/11TRANSCRIPT : Glenmark Pharmaceuticals Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/11TRANSCRIPT : Aurobindo Pharma Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/11Daiichi Sankyo and Astrazeneca’s ENHERTU® Approve in the U.S. as the First HER2 Directed Therapy for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
CI
08/11Intermedical Care and Lab Hospital Public Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/11Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 81,038 shares.
CI
08/11Vitalhub Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Senhwa Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Diagnósticos da América S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Biomm S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11TRANSCRIPT : Azenta, Inc. Presents at UBS Genomics 2.0 and Medtech Innovations Summit 2022, Aug-11-2022 04:00 PM
CI
08/11Panion & Bf Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Biotest Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Instituto Hermes Pardini S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Oneness Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Discover
08/12Diagnósticos da América S.A. authorizes a Buyback Plan.
CI
08/11Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Hapvida Participações e Investimentos S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2022
CI
08/11Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/11Agios Pharmaceuticals, Inc. Announces Publication of Phase 2 Data in The Lancet Demonstrating Safety and Efficacy of PYRUKYND® in Non-transfusion-dependent a- and ß-Thalassemia
CI
Prev.5  6  7  8  9   10  11  12  13  14Next